RecruitingPhase 4NCT06777758
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
The Comparison of Remimazolam or Propofol Used Alone Versus in Combination for Moderate Sedation During Endoscopic Examination and Treatment.
Sponsor
Kaohsiung Veterans General Hospital.
Enrollment
90 participants
Start Date
Feb 12, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria3
- Subjects are between 20-80 years old.
- Anesthesiologists rated ASA as between I and III.
- Patients undergoing upper gastrointestinal endoscopic examination or therapy.
Exclusion Criteria7
- Allergy to Propofol, Remimazolam, or opioid medications.
- Emergency surgery.
- Pregnancy.
- History of malignant hyperthermia.
- Impaired liver or kidney function.
- Airway difficulties due to pharyngeal tumors.
- Refusal to participate.
Interventions
DRUGRemimazolam
Remimazolam
DRUGPropofol
Propofol dose reduction ratio
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06777758
Related Trials
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
NCT073510718 locations
Probiotic Improve Constipation
NCT074624811 location
IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients
NCT074601411 location
Postoperative Hypocalcemia After Thyroidectomy
NCT074280571 location
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
NCT056037151 location